Open Access

MicroRNA‑4530 promotes angiogenesis by targeting VASH1 in breast carcinoma cells

  • Authors:
    • Tao Zhang
    • Li Jing
    • Hong Li
    • Linchao Ding
    • Dongdong Ai
    • Jianxin Lyu
    • Lianjin Zhong
  • View Affiliations

  • Published online on: April 28, 2017     https://doi.org/10.3892/ol.2017.6102
  • Pages: 111-118
  • Copyright: © Zhang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The results of our previous study revealed that microRNA (miRNA/miR)‑4530 was upregulated in the serum of patients with diabetic retinopathy. The TargetScan miRNA database was used to identify potential targets of miR‑4530 and vasohibin‑1 (VASH1) was predicted as one of the targets. The results of our previous study demonstrated that miR‑4530 was able to promote angiogenesis in human umbilical vein endothelial cells. Therefore, suppressing miR‑4530 may be a potentially novel approach towards inhibiting tumor angiogenesis. The present study aimed to investigate the function of miR‑4530 and determine whether miR‑4530 was able to regulate angiogenesis in breast carcinoma cells by targeting VASH1. MDA‑MB‑231 and MCF‑7 cells were transfected with miR‑4530 precursor, anti‑miR‑4530 and empty vector plasmids. The expression levels of miRNA and mRNA were detected using the reverse transcription‑quantitative polymerase chain reaction (RT‑qPCR). The expression levels of protein were detected using western blotting. Dual‑luciferase reporter assays were used to identify the target of miR‑4530. Furthermore, cell proliferation, cell cycle, apoptosis and tube formation assays were used to investigate the function of miR‑4530 in vitro. Nude mice were used in a subcutaneous tumor model in vivo study. The results of the present study demonstrated that miR‑4530 significantly suppressed proliferation and promoted apoptosis of breast carcinoma cells. In addition, miR‑4530 expression promoted angiogenesis in vitro. Results from the western blotting and RT‑qPCR revealed that VASH1 was significantly downregulated by miR‑4530 in breast carcinoma cells. The results of the present study suggest that miR‑4530 promotes angiogenesis, inhibits proliferation and induces apoptosis in breast carcinoma cells by suppressing the expression of VASH1.
View Figures
View References

Related Articles

Journal Cover

July-2017
Volume 14 Issue 1

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Zhang T, Jing L, Li H, Ding L, Ai D, Lyu J and Zhong L: MicroRNA‑4530 promotes angiogenesis by targeting VASH1 in breast carcinoma cells. Oncol Lett 14: 111-118, 2017
APA
Zhang, T., Jing, L., Li, H., Ding, L., Ai, D., Lyu, J., & Zhong, L. (2017). MicroRNA‑4530 promotes angiogenesis by targeting VASH1 in breast carcinoma cells. Oncology Letters, 14, 111-118. https://doi.org/10.3892/ol.2017.6102
MLA
Zhang, T., Jing, L., Li, H., Ding, L., Ai, D., Lyu, J., Zhong, L."MicroRNA‑4530 promotes angiogenesis by targeting VASH1 in breast carcinoma cells". Oncology Letters 14.1 (2017): 111-118.
Chicago
Zhang, T., Jing, L., Li, H., Ding, L., Ai, D., Lyu, J., Zhong, L."MicroRNA‑4530 promotes angiogenesis by targeting VASH1 in breast carcinoma cells". Oncology Letters 14, no. 1 (2017): 111-118. https://doi.org/10.3892/ol.2017.6102